RxSight, Inc. (RXST), an ophthalmic medical device company, on Tuesday announced that Chief Financial Officer Shelley Thunen is transitioning from her role.
Thunen will remain with the company until the earlier of the appointment of a replacement or January 31, 2026.
Thunen has agreed to continue supporting the company as a consultant following the transition.
The company did not disclose the reason for the transition.
On Monday, RxSight had closed at $12.23, 0.20 cents higher on the Nasdaq. In the after-market hours, the stock traded 1.55 cent lesser before ending the trade at $12.04.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.